W. Yasui et al., EXPRESSION OF P21(WAF1 CIP1) IN COLORECTAL ADENOMAS AND ADENOCARCINOMAS AND ITS CORRELATION WITH P53 PROTEIN EXPRESSION/, Pathology international, 47(7), 1997, pp. 470-477
The expression of p53-inducible cyclin-dependent kinase inhibitor, p21
(WAF1/CIP1) in non-neoplastic mucosa, adenoma and adenocarcinoma of th
e colorectum was examined by immunohistochemistry and western blotting
and its relation with the expression of p53 protein was analyzed. Non
neoplastic epithelial cells at the surface area showing no proliferati
ve activity expressed p21(WAF1/CIP1). The expression of p21(WAF1/CIP1)
immunohistochemically detected in 55% (206/377) of the adenomas and 6
6% (190/289) of the adenocarcinomas, respectively. The incidence of st
rongly positive cases was significantly higher in the adenocarcinomas
(27%) than in the adenomas (18%) (P<0.05). The incidence of cases with
strong p21(WAF1/CIP1) expression was higher in stages 0, 1 and 2 carc
inomas than in stages 3 and 4 carcinomas (P<0.05). A decrease in the i
ncidence of cases with strong expression was detected in carcinomas in
vading deeper than muscularis propria. The incidence of strongly posit
ive cases was significantly lower in carcinomas with lymph node metast
asis than those without metastasis (P<0.05). The expression of p21 as
well as p53 detected by western blotting was compatible with the resul
ts of immunohistochemistry in most cases examined. However, there was
no significant correlation between the expression of p21(WAF1/CIP1) an
d the abnormal accumulation of p53. These findings overall suggest tha
t: (i) the physiological expression of p21(WAF1/CIP1) may be associate
d with cellular senescence of colorectal mucosa; (ii) reduced expressi
on of p21(WAF1/CIP1) may participate in the progression of colorectal
carcinoma; and (iii) p53-independent pathway may be considerably invol
ved in the induction of p21(WAF1/CIP1).